Radiopharm Theranostics (ASX:RAD) Common Stock: A$176.56 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Radiopharm Theranostics Common Stock?

Radiopharm Theranostics ASX:RAD Common Stock is A$176.56 Mil as of Jun. 2025. The stock has 5 warning signs investors should review.

Radiopharm Theranostics's quarterly common stock increased from Jun. 2024 (A$100.68 Mil) to Dec. 2024 (A$168.28 Mil) and increased from Dec. 2024 (A$168.28 Mil) to Jun. 2025 (A$176.56 Mil).

Radiopharm Theranostics's annual common stock increased from Jun. 2023 (A$97.23 Mil) to Jun. 2024 (A$100.68 Mil) and increased from Jun. 2024 (A$100.68 Mil) to Jun. 2025 (A$176.56 Mil).

Radiopharm Theranostics Common Stock Historical Data

* Premium members only.

The historical data trend for Radiopharm Theranostics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Radiopharm Theranostics Common Stock Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Common Stock
86.76 97.23 100.68 176.56

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Common Stock Get a 7-Day Free Trial 97.23 99.06 100.68 168.28 176.56

Radiopharm Theranostics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$176.56 Mil mean?
Radiopharm Theranostics (ASX:RAD) has a Common Stock of A$176.56 Mil as of Jun. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Radiopharm Theranostics and its competitors.
Is Radiopharm Theranostics' Common Stock too high?
Radiopharm Theranostics' current Common Stock is A$176.56 Mil.
How does Radiopharm Theranostics' Common Stock compare to VRTX and REGN?
Radiopharm Theranostics' Common Stock of A$176.56 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Radiopharm Theranostics and its competitors. Radiopharm Theranostics's current Common Stock is A$176.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Radiopharm Theranostics stock overvalued right now?
Radiopharm Theranostics (ASX:RAD) has a current Common Stock of A$176.56 Mil. The current Common Stock is A$176.56 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Radiopharm Theranostics (ASX:RAD), the current Common Stock is A$176.56 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Radiopharm Theranostics Business Description

Other Exchanges RADX:USA
Address 62 Lygon Street, Suite 1, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.